英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

numark ltd - citric acid monohydrate - oral solution - 6.25mg/1ml

马来西亚 - 英文 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

idaman pharma manufacturing sdn bhd - citric acid,monohydrate; potassium citrate -

英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - citric acid monohydrate - oral solution - 6.25mg/1ml

马来西亚 - 英文 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

noripharma sdn. bhd. - citric acid monohydrate; potassium citrate -

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - citric acid monohydrate 4.8 mg/ml; glucose monohydrate 16 mg/ml; potassium citrate monohydrate 2.213 mg/ml; sodium chloride 2.528 mg/ml - oral solution - active: citric acid monohydrate 4.8 mg/ml glucose monohydrate 16 mg/ml potassium citrate monohydrate 2.213 mg/ml sodium chloride 2.528 mg/ml excipient: amaranth egg yellow colour c113 bj-fvegg00090 kiwi flavour 809-00036-01 potassium sorbate purified water sodium benzoate strawberry flavour sc574567 sucralose - relieves symptoms of dehydration and helps replace water and electrolytes lost due to vomiting, diarrhoea, heavy sweating, vigorous exercise and occasional hangovers

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - citric acid monohydrate 4.8 mg/ml; glucose monohydrate 16 mg/ml; potassium citrate monohydrate 2.213 mg/ml; sodium chloride 2.528 mg/ml - oral solution - active: citric acid monohydrate 4.8 mg/ml glucose monohydrate 16 mg/ml potassium citrate monohydrate 2.213 mg/ml sodium chloride 2.528 mg/ml excipient: amaranth carmellose sodium egg yellow colour c113 bj-fvegg00090 kiwi flavour 809-00036-01 potassium sorbate purified water sodium benzoate strawberry flavour sc574567 sucralose - relieves symptoms of dehydration and helps replace water and electrolytes lost due to vomiting, diarrhoea, heavy sweating, vigorous exercise and occasional hangovers

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

redland pharmaceuticals pty ltd - citric acid monohydrate, quantity: 4.8 mg/ml; glucose monohydrate, quantity: 16 mg/ml; potassium citrate, quantity: 2.2 mg/ml (equivalent: potassium, qty 0.8422 mg/ml); sodium chloride, quantity: 2.5 mg/ml - oral liquid - excipient ingredients: potassium sorbate; sodium benzoate; sodium citrate; sucralose - restore body fluid balance ; decrease/reduce/relieve symptoms of dehydration ; maintain/support body electrolyte balance ; helps restore body electrolyte balance ; decrease/reduce/relieve diarrhoea ; enhance/improve/promote/increase (state vitamin/mineral/nutrient) levels in the body ; maintain/support (state vitamin/mineral/nutrient) levels in the body

美国 - 英文 - NLM (National Library of Medicine)

westminster pharmaceuticals, llc - sodium citrate, unspecified form (unii: 1q73q2julr) (anhydrous citric acid - unii:xf417d3psl), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - sodium citrate and citric acid oral solution usp is an effective alkalinizing agent. it is useful in those conditions where long-term maintenance of an alkaline urine is desirable, and is of value in the alleviation of chronic metabolic acidosis, such as results from chronic renal insufficiency or the syndrome of renal tubular acidosis, especially when the administration of potassium salts is undesirable or contraindicated. this product is also useful for buffering and neutralizing gastric hydrochloric acid quickly and effectively. sodium citrate and citric acid oral solution usp is concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary ph around the clock, usually without the necessity of a 2 a.m. dose. this product alkalinizes the urine without producing a systemic alkalosis in the recommended dosage.this product is highly palatable, pleasant tasting,and tolerable, even when a administered for long periods. contraindicated in patients with sodium-restr

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - lodoxamide trometamol 1.78 mg/ml equivalent to 1 mg/ml lodoxamide - eye drops, solution - 1 mg/ml - active: lodoxamide trometamol 1.78 mg/ml equivalent to 1 mg/ml lodoxamide excipient: benzalkonium chloride citric acid monohydrate disodium edetate dihydrate hydrochloric acid hypromellose mannitol purified water sodium citrate dihydrate sodium hydroxide tyloxapol - lomide eye drops 0.1% are indicated in the treatment of non-infectious allergic conjunctivitis (vernal conjunctivitis, giant papillary conjunctivitis and seasonal allergic conjunctivitis). the aetiologic factors are unknown, but common airborne allergens and contact lenses have been implicated. lodoxamide trometamol may be effective against other ocular diseases where type-i, ige-mediated hypersensitivity (or mast cells) play a major role in the inflammatory process. prophylactic use of lomide eye drops will assist in minimising the allergic symptoms associated with seasonal allergic conjunctivitis.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - adrenaline (epinephrine) acid tartrate, quantity: 182 microgram/ml (equivalent: adrenaline (epinephrine), qty 100 microgram/ml) - injection, solution - excipient ingredients: sodium citrate dihydrate; sodium metabisulfite; dilute hydrochloric acid; water for injections; sodium chloride; citric acid monohydrate - adrenaline 1:10,000 is used as an adjunct in the management of cardiac arrest.